Skip to main content
Atrás
Watch Compare

Picard Medical, Inc.

Calidad de datos: 100%
PMI
NYSE Manufacturing Measuring & Analyzing Instruments
$1.01
▼ $0.01 (-0.98%)
Cap. Mercado: 75.93 M
Precio
$1.01
Cap. Mercado
75.93 M
Rango del Día
$1.00 — $1.05
Rango de 52 Semanas
$0.92 — $13.68
Volumen
35,218
Apertura $1.03
Promedio 50D / 200D
$1.34
24.34% below
Promedio 50D / 200D
$3.65
72.33% below

Quick Summary

Puntos Clave

Negative free cash flow of -15.67 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net Margin-546.60%
Op. Margin-268.36%

Seguridad

Debt / Equity
N/A
Current Ratio2.16
Interest CoverageN/A

Valoración

PE (TTM)
-2.81
Below sector avg (-1.47)
P/B Ratio9.53
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -2.8 -1.5
P/B 9.5 1.6
ROE % — -53.5
Net Margin % -546.6 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.94 M Net Income (TTM) -27.00 M
ROE N/A ROA -214.10%
Gross Margin -4.13% Operating Margin -268.36%
Net Margin -546.60% Free Cash Flow (TTM) -15.67 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.16
Interest Coverage N/A Asset Turnover 0.39
Working Capital 6.22 M Tangible Book Value 6.82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.81 Forward P/E N/A
P/B Ratio 9.53 P/S Ratio 15.37
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -20.64%
Market Cap 75.93 M Enterprise Value 73.12 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.07
FCF / Share -0.21 OCF / Share -0.21
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 58.04%
SBC-Adj. FCF -16.43 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue 4.94 M
Net Income -27.00 M
EPS (Diluted) —
Gross Profit -204,000.0
Operating Income -13.26 M
EBITDA —
R&D Expenses 3.05 M
SG&A Expenses 10.00 M
D&A 163,000.0
Interest Expense —
Income Tax 35,000.0

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 22.55 M
Total Liabilities 18.76 M
Shareholders' Equity 3.79 M
Total Debt —
Cash & Equivalents 7.45 M
Current Assets 20.73 M
Current Liabilities 18.70 M